首页> 外文期刊>Acta Radiologica >Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin
【24h】

Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin

机译:全身性S-1加顺铂治疗失败后,使用氟尿嘧啶,表柔比星和丝裂霉素C进行肝动脉灌注化疗的胃癌肝转移患者

获取原文
获取原文并翻译 | 示例
       

摘要

Background: For patients with liver metastases from gastric cancer (LMGC), combination chemotherapy with fluoropyrimidines and platinum agents has been recognized as standard treatment. However, the prognosis of hepatic progression after first-line treatment failure remains poor. When hepatic progression occurs, hepatic arterial infusion (HAI) chemotherapy may be helpful for preventing disease progression.
机译:背景:对于患有胃癌肝转移(LMGC)的患者,氟嘧啶和铂类药物联合化疗已被视为标准治疗方法。然而,一线治疗失败后肝病进展的预后仍然很差。当发生肝进展时,肝动脉输注(HAI)化疗可能有助于预防疾病进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号